These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Myocardial and coronary vessel dysfunction in diabetes I patients]. Konduracka E; Galicka-Latała D; Piwowarska W; Sieradzki J Przegl Lek; 2002; 59(7):514-8. PubMed ID: 12516240 [TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus. Guerci B; Böhme P; Kearney-Schwartz A; Zannad F; Drouin P Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis. Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193 [TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639 [TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction, atherosclerosis and diabetes. Najemnik C; Sinzinger H; Kritz H Acta Med Austriaca; 1999; 26(5):148-53. PubMed ID: 11512191 [TBL] [Abstract][Full Text] [Related]
17. Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis. Candido R; Zanetti M Ital Heart J; 2005 Sep; 6(9):703-20. PubMed ID: 16212072 [TBL] [Abstract][Full Text] [Related]
18. The role of nitric oxide in the development of diabetic angiopathy. Santilli F; Cipollone F; Mezzetti A; Chiarelli F Horm Metab Res; 2004 May; 36(5):319-35. PubMed ID: 15156413 [TBL] [Abstract][Full Text] [Related]
19. Why does diabetes mellitus increase the risk of cardiovascular disease? Shahab A Acta Med Indones; 2006; 38(1):33-41. PubMed ID: 16479030 [TBL] [Abstract][Full Text] [Related]
20. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes. Yamagishi S; Ueda S; Okuda S Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]